EUVIMEDEUVIMED entdecken
Leserbrief

Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib

Fadi G Haddad, Cedric Nasnas, Koji Sasaki, Shilpa Paul, Ghayas C Issa, Caitlin Rausch, Elias Jabbour, Hagop Kantarjian

Clinical Lymphoma Myeloma and Leukemia · 2024

DOI: 10.1016/j.clml.2024.02.014 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2024. Verfasst von Fadi G Haddad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: fhaddad@mdanderson.org. Hauptthemen laut MEDLINE: Dasatinib, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Proton Pump Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DasatinibLeukemia, Myelogenous, Chronic, BCR-ABL PositiveProton Pump InhibitorsHumansMaleFemaleMiddle AgedAgedProtein Kinase InhibitorsAdultTreatment OutcomeAntineoplastic Agents

Stichwörter der Autor:innen

AntacidH2 blockerResponseTyrosine kinase inhibitor

Substanzen

DasatinibProton Pump InhibitorsProtein Kinase InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: fhaddad@mdanderson.org.
  • Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.

Zitieren

APA

Haddad, F. G., Nasnas, C., Sasaki, K., Paul, S., Issa, G. C., Rausch, C., Jabbour, E., & Kantarjian, H. (2024). Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2024.02.014

Vancouver

Haddad FG, Nasnas C, Sasaki K, Paul S, Issa GC, Rausch C, et al. Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib. Clinical Lymphoma Myeloma and Leukemia. 2024. doi:10.1016/j.clml.2024.02.014

BibTeX
@article{Haddad2024,
  author = {Haddad, Fadi G and Nasnas, Cedric and Sasaki, Koji and Paul, Shilpa and Issa, Ghayas C and Rausch, Caitlin and Jabbour, Elias and Kantarjian, Hagop},
  title = {Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2024},
  doi = {10.1016/j.clml.2024.02.014}
}
Kostenlos starten →